Other

Royalty Pharma·Balance Sheet Statement·24 metrics

Breakdown

Loading...

Metrics

Nonperforming Loans and Leases Percentage

Accrued liabilities

Quarterly conversion basis (in shares)

Number of votes per share

Less: net unamortized discount

Deferred stock, par value (in dollars per share)

Deferred stock, issued (in shares)

Deferred stock, outstanding (in shares)

Equity method investments (Note 11)

Financing Receivable, Allowance For Credit Loss, Changes In Expected Cash Flows

Financing Receivable, Allowance For Credit Loss, Cumulative Adjustment And Credit Loss Expense (Reversal)

Financing Receivables, After Allowance For Credit Loss Changes In Expected Cash Flows

Lessee Operating Lease Liability Payments Due

Thereafter

Lessee Operating Lease Liability Undiscounted Excess Amount

Noncontrolling interests in subsidiaries

Number of classes of stock

Number of noncontrolling interests created

Total Commitments

Unfunded Commitments

Share price (in dollars per share)

Share Repurchase Program, Authorized, Amount

Share Repurchase Program, Remaining Authorized, Amount

Remainder of Fiscal Year 2024